Your browser doesn't support javascript.
loading
Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations.
Ladd, Brendon; Mazzola, Anne Marie; Bihani, Teeru; Lai, Zhongwu; Bradford, James; Collins, Michael; Barry, Evan; Goeppert, Anne U; Weir, Hazel M; Hearne, Kelly; Renshaw, Jonathan G; Mohseni, Morvarid; Hurt, Elaine; Jalla, Sanjoo; Bao, Haifeng; Hollingsworth, Robert; Reimer, Corinne; Zinda, Michael; Fawell, Stephen; D'Cruz, Celina M.
Afiliación
  • Ladd B; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • Mazzola AM; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • Bihani T; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • Lai Z; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • Bradford J; Oncology iMed, AstraZeneca, Alderley Park, Macclesfield, UK.
  • Collins M; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • Barry E; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • Goeppert AU; Oncology iMed, AstraZeneca, Alderley Park, Macclesfield, UK.
  • Weir HM; Oncology iMed, AstraZeneca, Alderley Park, Macclesfield, UK.
  • Hearne K; Oncology iMed, AstraZeneca, Alderley Park, Macclesfield, UK.
  • Renshaw JG; Oncology iMed, AstraZeneca, Alderley Park, Macclesfield, UK.
  • Mohseni M; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • Hurt E; Oncology, Medimmune, Gaithersburg, MD, USA.
  • Jalla S; Oncology, Medimmune, Gaithersburg, MD, USA.
  • Bao H; Oncology, Medimmune, Gaithersburg, MD, USA.
  • Hollingsworth R; Oncology, Medimmune, Gaithersburg, MD, USA.
  • Reimer C; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • Zinda M; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • Fawell S; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
  • D'Cruz CM; Oncology iMed, AstraZeneca, Gatehouse Park, Waltham, MA, USA.
Oncotarget ; 7(34): 54120-54136, 2016 Aug 23.
Article en En | MEDLINE | ID: mdl-27472462
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrógenos / Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina / Serina-Treonina Quinasas TOR / Mutación Límite: Animals / Female / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrógenos / Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina / Serina-Treonina Quinasas TOR / Mutación Límite: Animals / Female / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos